NCT00550095View on ClinicalTrials.gov

To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

509

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

MicroalbuminuriaProteinuria

Interventions

DRUG

valsartan

Trial Locations (1)

Unknown

Novartis Investigative Site ,, Cairo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY